Just curious because Toxoplasma gondii establishes a latent CNS-infection in a large portion of the world's population and becomes a major concern in immunocompromising conditions such as AIDS, but does not seem to be much of a concern during natalizumab therapy, which is administered to MS patients to block immune cell surveillance/trafficking into the CNS.